Browse the inventory
Medication records
Presence in this inventory is not a safety designation, preferred-agent ranking, or commissioned recommendation.
No records match these filters. Clear the filters or try a generic name, component, class, or route.
MED-277Prepopulated workbench
No brand or product examples populated
- Class
- Nonprescription/emerging psychoactive — nutrient/amino acid
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Nonprescription mood/sleep exposure
MED-226Prepopulated workbench
No brand or product examples populated
- Class
- Substance-use disorder — alcohol
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Approved or off-label medication considered in alcohol use disorder
MED-020Prepopulated workbench
Valdoxan
- Class
- Antidepressants — other/multimodal
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Antidepressant; mechanism and approved indications vary
MED-168Prepopulated workbench
No brand or product examples populated
- Class
- Benzodiazepines
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Benzodiazepine-class anxiolytic, sedative, anticonvulsant, or procedural agent
MED-160Prepopulated workbench
No brand or product examples populated
- Class
- ADHD/psychostimulants — off-label
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Off-label ADHD treatment; cross-reference primary approved indications
MED-088Prepopulated workbench
No brand or product examples populated
- Class
- Antipsychotics — first generation/related
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Antipsychotic or closely related dopamine-antagonist drug
MED-025Prepopulated workbench
No brand or product examples populated
- Class
- Antidepressants — tricyclic/tetracyclic
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Tricyclic or tetracyclic antidepressant
MED-034Prepopulated workbench
No brand or product examples populated
- Class
- Antidepressants — tricyclic/tetracyclic
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Tricyclic or tetracyclic antidepressant
MED-143Prepopulated workbench
Evekeo
- Class
- ADHD/psychostimulants — amphetamine
- Formulation / route
- Oral tablet or orally disintegrating tablet
- Psychiatric-use scope
- Prescription amphetamine stimulant for ADHD or narcolepsy
MED-103Prepopulated workbench
No brand or product examples populated
- Class
- Antipsychotics — second generation/newer
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Second-generation or newer antipsychotic
MED-129Prepopulated workbench
Aristada
- Class
- Antipsychotics — long-acting injectable
- Formulation / route
- Intramuscular extended-release suspension; every 4, 6, or 8 weeks
- Psychiatric-use scope
- Long-acting antipsychotic formulation
MED-130Prepopulated workbench
Aristada Initio
- Class
- Antipsychotics — long-acting injectable
- Formulation / route
- One-time intramuscular initiation dose; not a maintenance interval
- Psychiatric-use scope
- Long-acting antipsychotic formulation
MED-127Prepopulated workbench
Abilify Maintena
- Class
- Antipsychotics — long-acting injectable
- Formulation / route
- Intramuscular extended-release suspension; monthly
- Psychiatric-use scope
- Long-acting antipsychotic formulation
MED-128Prepopulated workbench
Abilify Asimtufii
- Class
- Antipsychotics — long-acting injectable
- Formulation / route
- Intramuscular extended-release suspension; every 2 months
- Psychiatric-use scope
- Long-acting antipsychotic formulation
MED-162Prepopulated workbench
No brand or product examples populated
- Class
- Wake-promoting/narcolepsy
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Wake-promoting or narcolepsy/cataplexy treatment
MED-104Prepopulated workbench
No brand or product examples populated
- Class
- Antipsychotics — second generation/newer
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Second-generation or newer antipsychotic
MED-270Prepopulated workbench
No brand or product examples populated
- Class
- Nonprescription/emerging psychoactive — cannabinoid/plant
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Nonprescription stress/anxiety/sleep exposure
MED-154Prepopulated workbench
No brand or product examples populated
- Class
- ADHD/psychostimulants — nonstimulant
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Nonstimulant ADHD treatment
MED-230Prepopulated workbench
No brand or product examples populated
- Class
- Substance-use disorder — alcohol
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Approved or off-label medication considered in alcohol use disorder
MED-248Prepopulated workbench
No brand or product examples populated
- Class
- Psychiatric adjuncts — movement disorders/EPS
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Treatment of extrapyramidal symptoms or tardive dyskinesia; indication varies
MED-093Prepopulated workbench
No brand or product examples populated
- Class
- Antipsychotics — first generation/related
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Antipsychotic or closely related dopamine-antagonist drug
MED-049Prepopulated workbench
Zulresso
- Class
- Antidepressants — perinatal neuroactive steroid
- Formulation / route
- Continuous intravenous infusion (historical REMS product)
- Psychiatric-use scope
- Postpartum depression treatment; former US approval
MED-107Prepopulated workbench
No brand or product examples populated
- Class
- Antipsychotics — second generation/newer
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Second-generation or newer antipsychotic
MED-182Prepopulated workbench
No brand or product examples populated
- Class
- Benzodiazepines
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Benzodiazepine-class anxiolytic, sedative, anticonvulsant, or procedural agent
MED-253Prepopulated workbench
No brand or product examples populated
- Class
- Psychiatric adjuncts — hyperprolactinemia/NMS/catatonia
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Nonpsychotropic or adjunctive use in medication adverse effects, catatonia, or NMS
MED-187Prepopulated workbench
No brand or product examples populated
- Class
- Benzodiazepines
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Benzodiazepine-class anxiolytic, sedative, anticonvulsant, or procedural agent
MED-214Prepopulated workbench
Belbuca
- Class
- Substance-use disorder — opioid
- Formulation / route
- Buccal film
- Psychiatric-use scope
- FDA-approved for chronic pain, not opioid use disorder
MED-216Prepopulated workbench
Sublocade
- Class
- Substance-use disorder — opioid
- Formulation / route
- Subcutaneous depot injection; monthly
- Psychiatric-use scope
- Medication for opioid use disorder, withdrawal, or overdose rescue
MED-217Prepopulated workbench
Brixadi
- Class
- Substance-use disorder — opioid
- Formulation / route
- Subcutaneous depot injection; weekly or monthly
- Psychiatric-use scope
- Medication for opioid use disorder, withdrawal, or overdose rescue
MED-219Prepopulated workbench
Probuphine
- Class
- Substance-use disorder — opioid
- Formulation / route
- Subdermal implant; six-month exposure
- Psychiatric-use scope
- Medication for opioid use disorder, withdrawal, or overdose rescue
MED-220Prepopulated workbench
Sixmo
- Class
- Substance-use disorder — opioid
- Formulation / route
- Subdermal implant; six-month exposure
- Psychiatric-use scope
- Medication for opioid use disorder, withdrawal, or overdose rescue
MED-218Prepopulated workbench
Buvidal
- Class
- Substance-use disorder — opioid
- Formulation / route
- Subcutaneous prolonged-release injection; weekly or monthly
- Psychiatric-use scope
- Medication for opioid use disorder, withdrawal, or overdose rescue
MED-213Prepopulated workbench
Subutex (historical brand) · generics
- Class
- Substance-use disorder — opioid
- Formulation / route
- Sublingual tablet
- Psychiatric-use scope
- Opioid use disorder treatment
MED-215Prepopulated workbench
Suboxone · Zubsolv · Bunavail (historical)
- Class
- Substance-use disorder — opioid
- Formulation / route
- Sublingual film/tablet or buccal film, product-specific
- Psychiatric-use scope
- Opioid use disorder treatment
MED-012Prepopulated workbench
No brand or product examples populated
- Class
- Antidepressants — other/multimodal
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Antidepressant; mechanism and approved indications vary
MED-240Prepopulated workbench
No brand or product examples populated
- Class
- Substance-use disorder — stimulant
- Formulation / route
- Studied regimen uses separate agents/formulations; not a universally approved stimulant-use-disorder product
- Psychiatric-use scope
- Off-label/investigational pharmacotherapy for stimulant use disorder
MED-238Prepopulated workbench
Zyban · generics
- Class
- Substance-use disorder — nicotine
- Formulation / route
- Oral sustained-release tablet
- Psychiatric-use scope
- Smoking-cessation treatment; cross-reference antidepressant bupropion
MED-189Prepopulated workbench
No brand or product examples populated
- Class
- Anxiolytics/symptom-targeted
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Anxiolytic or symptom-targeted off-label psychiatric medication
MED-209Prepopulated workbench
No brand or product examples populated
- Class
- Insomnia — antihistamine/legacy sedative
- Formulation / route
- Oral combination products
- Psychiatric-use scope
- Legacy sedative exposure; not an insomnia treatment indication
MED-254Prepopulated workbench
No brand or product examples populated
- Class
- Psychiatric adjuncts — hyperprolactinemia/NMS/catatonia
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Nonpsychotropic or adjunctive use in medication adverse effects, catatonia, or NMS
MED-166Prepopulated workbench
Xywav
- Class
- Wake-promoting/narcolepsy
- Formulation / route
- Oral solution; once- or twice-nightly depending on indication/regimen
- Psychiatric-use scope
- Wake-promoting or narcolepsy/cataplexy treatment
MED-246Prepopulated workbench
Epidiolex
- Class
- Substance-use disorder — cannabis
- Formulation / route
- Oral solution
- Psychiatric-use scope
- FDA-approved for specified seizure disorders; investigational/off-label for cannabis use disorder/psychiatric uses
MED-265Prepopulated workbench
CBD oils, gummies, beverages, topicals
- Class
- Nonprescription/emerging psychoactive — cannabinoid/plant
- Formulation / route
- Consumer oral/topical/inhaled products; quality varies
- Psychiatric-use scope
- Nonprescription cannabinoid exposure; distinguish from Epidiolex
MED-264Prepopulated workbench
Cannabis · THC products
- Class
- Nonprescription/emerging psychoactive — cannabinoid/plant
- Formulation / route
- Inhaled, oral, sublingual, topical, or other consumer products
- Psychiatric-use scope
- Nonprescription/recreational psychoactive exposure; distinguish from FDA-approved dronabinol/nabilone
MED-061Prepopulated workbench
No brand or product examples populated
- Class
- Mood stabilizers/antiseizure — core
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Core mood stabilizer/antiseizure medication; psychiatric and epilepsy indications must be separated
MED-108Prepopulated workbench
No brand or product examples populated
- Class
- Antipsychotics — second generation/newer
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Second-generation or newer antipsychotic
MED-153Prepopulated workbench
Simtriyo
- Class
- ADHD/psychostimulants — novel agent
- Formulation / route
- Oral extended-release capsule; once daily
- Psychiatric-use scope
- FDA-approved treatment of ADHD in adults and pediatric patients aged 6 years and older who weigh at least 20 kg
MED-211Prepopulated workbench
No brand or product examples populated
- Class
- Insomnia — antihistamine/legacy sedative
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Sedating antihistamine, barbiturate, or legacy hypnotic
MED-174Prepopulated workbench
No brand or product examples populated
- Class
- Benzodiazepines
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Benzodiazepine-class anxiolytic, sedative, anticonvulsant, or procedural agent
MED-073Prepopulated workbench
No brand or product examples populated
- Class
- Antipsychotics — first generation/related
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Antipsychotic or closely related dopamine-antagonist drug
MED-003Prepopulated workbench
No brand or product examples populated
- Class
- Antidepressants — SSRI
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- SSRI antidepressant; mood/anxiety/OCD indications vary
MED-181Prepopulated workbench
No brand or product examples populated
- Class
- Benzodiazepines
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Benzodiazepine-class anxiolytic, sedative, anticonvulsant, or procedural agent
MED-029Prepopulated workbench
No brand or product examples populated
- Class
- Antidepressants — tricyclic/tetracyclic
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Tricyclic or tetracyclic antidepressant
MED-173Prepopulated workbench
No brand or product examples populated
- Class
- Benzodiazepines
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Benzodiazepine-class anxiolytic, sedative, anticonvulsant, or procedural agent
MED-159Prepopulated workbench
Kapvay
- Class
- ADHD/psychostimulants — nonstimulant
- Formulation / route
- Oral extended-release tablet; ADHD indication
- Psychiatric-use scope
- Nonstimulant ADHD treatment
MED-158Prepopulated workbench
No brand or product examples populated
- Class
- ADHD/psychostimulants — nonstimulant
- Formulation / route
- Oral immediate-release tablet; ADHD use off-label
- Psychiatric-use scope
- Nonstimulant ADHD treatment
MED-175Prepopulated workbench
No brand or product examples populated
- Class
- Benzodiazepines
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Benzodiazepine-class anxiolytic, sedative, anticonvulsant, or procedural agent
MED-097Prepopulated workbench
No brand or product examples populated
- Class
- Antipsychotics — second generation/newer
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Second-generation or newer antipsychotic
MED-281Prepopulated workbench
No brand or product examples populated
- Class
- Nonprescription/emerging psychoactive — stimulant
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Nonmedical stimulant exposure and stimulant use disorder
MED-279Prepopulated workbench
No brand or product examples populated
- Class
- Nonprescription/emerging psychoactive — stimulant
- Formulation / route
- Beverage, powder, tablet, liquid concentrate, or other consumer form
- Psychiatric-use scope
- Nonprescription stimulant exposure
MED-239Prepopulated workbench
Cytisinicline · Tabex (jurisdiction-specific)
- Class
- Substance-use disorder — nicotine
- Formulation / route
- Oral tablet regimen
- Psychiatric-use scope
- Nicotinic partial agonist smoking-cessation treatment
MED-256Prepopulated workbench
No brand or product examples populated
- Class
- Psychiatric adjuncts — hyperprolactinemia/NMS/catatonia
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Nonpsychotropic or adjunctive use in medication adverse effects, catatonia, or NMS
MED-202Prepopulated workbench
No brand or product examples populated
- Class
- Insomnia — orexin antagonist
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Dual orexin receptor antagonist for insomnia
MED-028Prepopulated workbench
No brand or product examples populated
- Class
- Antidepressants — tricyclic/tetracyclic
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Tricyclic or tetracyclic antidepressant
MED-008Prepopulated workbench
No brand or product examples populated
- Class
- Antidepressants — SNRI/dual reuptake
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- SNRI antidepressant; approved psychiatric indications vary
MED-251Prepopulated workbench
No brand or product examples populated
- Class
- Psychiatric adjuncts — movement disorders/EPS
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Treatment of extrapyramidal symptoms or tardive dyskinesia; indication varies
MED-151Prepopulated workbench
Focalin · Focalin XR
- Class
- ADHD/psychostimulants — methylphenidate
- Formulation / route
- Oral immediate- and extended-release products
- Psychiatric-use scope
- Prescription methylphenidate-class stimulant for ADHD
MED-141Prepopulated workbench
No brand or product examples populated
- Class
- ADHD/psychostimulants — amphetamine
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Prescription amphetamine stimulant for ADHD or narcolepsy
MED-146Prepopulated workbench
Xelstrym
- Class
- ADHD/psychostimulants — amphetamine
- Formulation / route
- Transdermal system; once daily wear period
- Psychiatric-use scope
- Prescription amphetamine stimulant for ADHD or narcolepsy
MED-048Prepopulated workbench
No brand or product examples populated
- Class
- Antidepressants — rapid-acting/glutamatergic
- Formulation / route
- Oral; OTC cough products or compounded/off-label regimens
- Psychiatric-use scope
- Component of approved combinations and an off-label/research psychiatric agent
MED-019Prepopulated workbench
Auvelity
- Class
- Antidepressants — other/multimodal
- Formulation / route
- Oral bilayer tablet: dextromethorphan immediate-release + bupropion extended-release
- Psychiatric-use scope
- Antidepressant; mechanism and approved indications vary
MED-259Prepopulated workbench
Nuedexta
- Class
- Special psychiatric indications — pseudobulbar affect
- Formulation / route
- Oral capsule
- Psychiatric-use scope
- Pseudobulbar affect
MED-172Prepopulated workbench
No brand or product examples populated
- Class
- Benzodiazepines
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Benzodiazepine-class anxiolytic, sedative, anticonvulsant, or procedural agent
MED-206Prepopulated workbench
No brand or product examples populated
- Class
- Insomnia — antihistamine/legacy sedative
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Sedating antihistamine, barbiturate, or legacy hypnotic
MED-140Prepopulated workbench
No brand or product examples populated
- Class
- Emergency agitation — short-acting formulations
- Formulation / route
- Intramuscular or intravenous injection
- Psychiatric-use scope
- Short-acting formulation used in emergency agitation or acute symptom management
MED-227Prepopulated workbench
No brand or product examples populated
- Class
- Substance-use disorder — alcohol
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Approved or off-label medication considered in alcohol use disorder
MED-059Prepopulated workbench
No brand or product examples populated
- Class
- Mood stabilizers/antiseizure — core
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Core mood stabilizer/antiseizure medication; psychiatric and epilepsy indications must be separated
MED-260Prepopulated workbench
No brand or product examples populated
- Class
- Special psychiatric indications — cholinesterase inhibitor appendix
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Cognitive-disorder medication included for rare-exposure completeness
MED-036Prepopulated workbench
No brand or product examples populated
- Class
- Antidepressants — tricyclic/tetracyclic
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Tricyclic or tetracyclic antidepressant
MED-030Prepopulated workbench
No brand or product examples populated
- Class
- Antidepressants — tricyclic/tetracyclic
- Formulation / route
- Oral capsule/concentrate; antidepressant dose range
- Psychiatric-use scope
- Tricyclic or tetracyclic antidepressant
MED-031Prepopulated workbench
Silenor
- Class
- Antidepressants — tricyclic/tetracyclic
- Formulation / route
- Oral tablet, 3 mg or 6 mg at bedtime
- Psychiatric-use scope
- Insomnia treatment; pharmacologically lower-dose formulation than antidepressant use
MED-207Prepopulated workbench
No brand or product examples populated
- Class
- Insomnia — antihistamine/legacy sedative
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Sedating antihistamine, barbiturate, or legacy hypnotic
MED-243Prepopulated workbench
No brand or product examples populated
- Class
- Substance-use disorder — cannabis
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- FDA-approved cannabinoid for nonpsychiatric indications; investigational/off-label for cannabis use disorder
MED-138Prepopulated workbench
No brand or product examples populated
- Class
- Emergency agitation — short-acting formulations
- Formulation / route
- Intramuscular or intravenous injection
- Psychiatric-use scope
- Short-acting formulation used in emergency agitation or acute symptom management
MED-009Prepopulated workbench
No brand or product examples populated
- Class
- Antidepressants — SNRI/dual reuptake
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- SNRI antidepressant; approved psychiatric indications vary
MED-004Prepopulated workbench
No brand or product examples populated
- Class
- Antidepressants — SSRI
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- SSRI antidepressant; mood/anxiety/OCD indications vary
MED-047Prepopulated workbench
Spravato
- Class
- Antidepressants — rapid-acting/glutamatergic
- Formulation / route
- Intranasal spray administered under a REMS program
- Psychiatric-use scope
- Rapid-acting or glutamatergic psychiatric treatment
MED-177Prepopulated workbench
No brand or product examples populated
- Class
- Benzodiazepines
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Benzodiazepine-class anxiolytic, sedative, anticonvulsant, or procedural agent
MED-198Prepopulated workbench
No brand or product examples populated
- Class
- Insomnia — Z-drug
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Nonbenzodiazepine hypnotic
MED-193Prepopulated workbench
No brand or product examples populated
- Class
- Anxiolytics/symptom-targeted
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Anxiolytic or symptom-targeted off-label psychiatric medication
MED-188Prepopulated workbench
No brand or product examples populated
- Class
- Benzodiazepines
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Benzodiazepine-class anxiolytic, sedative, anticonvulsant, or procedural agent
MED-247Prepopulated workbench
No brand or product examples populated
- Class
- Substance-use disorder — sedative withdrawal
- Formulation / route
- Intravenous injection
- Psychiatric-use scope
- Benzodiazepine reversal; specialized/high-risk use in sedative-hypnotic withdrawal
MED-185Prepopulated workbench
No brand or product examples populated
- Class
- Benzodiazepines
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Benzodiazepine-class anxiolytic, sedative, anticonvulsant, or procedural agent
MED-001Prepopulated workbench
No brand or product examples populated
- Class
- Antidepressants — SSRI
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- SSRI antidepressant; mood/anxiety/OCD indications vary
MED-086Prepopulated workbench
No brand or product examples populated
- Class
- Antipsychotics — first generation/related
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Antipsychotic or closely related dopamine-antagonist drug
MED-131Prepopulated workbench
No brand or product examples populated
- Class
- Antipsychotics — long-acting injectable
- Formulation / route
- Intramuscular depot injection; interval product-specific
- Psychiatric-use scope
- Long-acting antipsychotic formulation
MED-074Prepopulated workbench
No brand or product examples populated
- Class
- Antipsychotics — first generation/related
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Antipsychotic or closely related dopamine-antagonist drug
MED-116Prepopulated workbench
No brand or product examples populated
- Class
- Antipsychotics — long-acting injectable
- Formulation / route
- Intramuscular or subcutaneous depot injection; interval individualized
- Psychiatric-use scope
- Long-acting antipsychotic formulation
MED-178Prepopulated workbench
No brand or product examples populated
- Class
- Benzodiazepines
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Benzodiazepine-class anxiolytic, sedative, anticonvulsant, or procedural agent
MED-006Prepopulated workbench
No brand or product examples populated
- Class
- Antidepressants — SSRI
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- SSRI antidepressant; mood/anxiety/OCD indications vary
MED-273Prepopulated workbench
No brand or product examples populated
- Class
- Nonprescription/emerging psychoactive — nutrient/amino acid
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Nutrient/adjunct exposure; distinguish from L-methylfolate
MED-065Prepopulated workbench
No brand or product examples populated
- Class
- Mood stabilizers/antiseizure — other
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Antiseizure medication with off-label psychiatric use; established bipolar efficacy must not be assumed
MED-262Prepopulated workbench
No brand or product examples populated
- Class
- Special psychiatric indications — cholinesterase inhibitor appendix
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Cognitive-disorder medication included for rare-exposure completeness
MED-018Prepopulated workbench
Exxua
- Class
- Antidepressants — other/multimodal
- Formulation / route
- Oral extended-release tablet; once daily
- Psychiatric-use scope
- Antidepressant; mechanism and approved indications vary
MED-258Prepopulated workbench
No brand or product examples populated
- Class
- Psychiatric adjuncts — metabolic mitigation
- Formulation / route
- Product-specific oral or subcutaneous formulations
- Psychiatric-use scope
- Nonpsychotropic preconception/metabolic co-medication
MED-157Prepopulated workbench
Intuniv
- Class
- ADHD/psychostimulants — nonstimulant
- Formulation / route
- Oral extended-release tablet; once daily
- Psychiatric-use scope
- Nonstimulant ADHD treatment
MED-156Prepopulated workbench
No brand or product examples populated
- Class
- ADHD/psychostimulants — nonstimulant
- Formulation / route
- Oral immediate-release tablet; FDA-approved for hypertension, ADHD use off-label
- Psychiatric-use scope
- Nonstimulant ADHD treatment
MED-075Prepopulated workbench
No brand or product examples populated
- Class
- Antipsychotics — first generation/related
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Antipsychotic or closely related dopamine-antagonist drug
MED-115Prepopulated workbench
No brand or product examples populated
- Class
- Antipsychotics — long-acting injectable
- Formulation / route
- Intramuscular depot injection; usually every 4 weeks
- Psychiatric-use scope
- Long-acting antipsychotic formulation
MED-135Prepopulated workbench
No brand or product examples populated
- Class
- Emergency agitation — short-acting formulations
- Formulation / route
- Intramuscular injection; intravenous psychiatric use is off-label
- Psychiatric-use scope
- Short-acting formulation used in emergency agitation or acute symptom management
MED-190Prepopulated workbench
No brand or product examples populated
- Class
- Anxiolytics/symptom-targeted
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Anxiolytic or symptom-targeted off-label psychiatric medication
MED-286Prepopulated workbench
No brand or product examples populated
- Class
- Nonprescription/emerging psychoactive — psychedelic/entactogen
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Investigational substance-use-disorder intervention and nonmedical exposure
MED-105Prepopulated workbench
No brand or product examples populated
- Class
- Antipsychotics — second generation/newer
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Second-generation or newer antipsychotic
MED-027Prepopulated workbench
No brand or product examples populated
- Class
- Antidepressants — tricyclic/tetracyclic
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Tricyclic or tetracyclic antidepressant
MED-274Prepopulated workbench
No brand or product examples populated
- Class
- Nonprescription/emerging psychoactive — nutrient/amino acid
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Nonprescription psychiatric adjunct exposure
MED-040Prepopulated workbench
No brand or product examples populated
- Class
- Antidepressants — MAOI
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Monoamine oxidase inhibitor antidepressant
MED-269Prepopulated workbench
No brand or product examples populated
- Class
- Nonprescription/emerging psychoactive — cannabinoid/plant
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Nonprescription anxiety/sedative exposure
MED-046Prepopulated workbench
No brand or product examples populated
- Class
- Antidepressants — rapid-acting/glutamatergic
- Formulation / route
- Compounded oral, sublingual, intranasal, or other nonapproved formulations
- Psychiatric-use scope
- Off-label/compounded rapid-acting antidepressant use
MED-045Prepopulated workbench
No brand or product examples populated
- Class
- Antidepressants — rapid-acting/glutamatergic
- Formulation / route
- Intramuscular injection; psychiatric use is off-label
- Psychiatric-use scope
- Off-label emergency agitation or rapid-acting psychiatric use
MED-044Prepopulated workbench
No brand or product examples populated
- Class
- Antidepressants — rapid-acting/glutamatergic
- Formulation / route
- Intravenous infusion; psychiatric use is off-label
- Psychiatric-use scope
- Rapid-acting off-label antidepressant and emergency/acute use
MED-266Prepopulated workbench
No brand or product examples populated
- Class
- Nonprescription/emerging psychoactive — cannabinoid/plant
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Nonapproved psychoactive botanical exposure
MED-054Prepopulated workbench
Deplin
- Class
- Antidepressant augmentation
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Adjunctive depression product; also sold in nonprescription formulations
MED-276Prepopulated workbench
No brand or product examples populated
- Class
- Nonprescription/emerging psychoactive — nutrient/amino acid
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Nonprescription mood/sleep exposure
MED-070Prepopulated workbench
No brand or product examples populated
- Class
- Mood stabilizers/antiseizure — other
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Antiseizure medication with off-label psychiatric use; established bipolar efficacy must not be assumed
MED-062Prepopulated workbench
No brand or product examples populated
- Class
- Mood stabilizers/antiseizure — core
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Core mood stabilizer/antiseizure medication; psychiatric and epilepsy indications must be separated
MED-272Prepopulated workbench
No brand or product examples populated
- Class
- Nonprescription/emerging psychoactive — cannabinoid/plant
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Nonprescription anxiety exposure
MED-201Prepopulated workbench
No brand or product examples populated
- Class
- Insomnia — orexin antagonist
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Dual orexin receptor antagonist for insomnia
MED-067Prepopulated workbench
No brand or product examples populated
- Class
- Mood stabilizers/antiseizure — other
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Antiseizure medication with off-label psychiatric use; established bipolar efficacy must not be assumed
MED-085Prepopulated workbench
No brand or product examples populated
- Class
- Antipsychotics — first generation/related
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Antipsychotic or closely related dopamine-antagonist drug
MED-010Prepopulated workbench
No brand or product examples populated
- Class
- Antidepressants — SNRI/dual reuptake
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- SNRI antidepressant; approved psychiatric indications vary
MED-051Prepopulated workbench
No brand or product examples populated
- Class
- Antidepressant augmentation
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Thyroid hormone used off-label for antidepressant augmentation
MED-144Prepopulated workbench
Vyvanse
- Class
- ADHD/psychostimulants — amphetamine
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Prescription amphetamine stimulant for ADHD or narcolepsy
MED-056Prepopulated workbench
No brand or product examples populated
- Class
- Mood stabilizers/antiseizure — core
- Formulation / route
- Oral immediate- or extended-release tablet/capsule
- Psychiatric-use scope
- Core mood stabilizer/antiseizure medication; psychiatric and epilepsy indications must be separated
MED-057Prepopulated workbench
No brand or product examples populated
- Class
- Mood stabilizers/antiseizure — core
- Formulation / route
- Oral solution
- Psychiatric-use scope
- Core mood stabilizer/antiseizure medication; psychiatric and epilepsy indications must be separated
MED-037Prepopulated workbench
No brand or product examples populated
- Class
- Antidepressants — tricyclic/tetracyclic
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Tricyclic or tetracyclic antidepressant
MED-224Prepopulated workbench
No brand or product examples populated
- Class
- Substance-use disorder — opioid
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Medication for opioid use disorder, withdrawal, or overdose rescue
MED-169Prepopulated workbench
No brand or product examples populated
- Class
- Benzodiazepines
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Benzodiazepine-class anxiolytic, sedative, anticonvulsant, or procedural agent
MED-139Prepopulated workbench
No brand or product examples populated
- Class
- Emergency agitation — short-acting formulations
- Formulation / route
- Intramuscular or intravenous injection
- Psychiatric-use scope
- Short-acting formulation used in emergency agitation or acute symptom management
MED-184Prepopulated workbench
No brand or product examples populated
- Class
- Benzodiazepines
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Benzodiazepine-class anxiolytic, sedative, anticonvulsant, or procedural agent
MED-079Prepopulated workbench
No brand or product examples populated
- Class
- Antipsychotics — first generation/related
- Formulation / route
- Oral capsule
- Psychiatric-use scope
- Antipsychotic or closely related dopamine-antagonist drug
MED-080Prepopulated workbench
Adasuve
- Class
- Antipsychotics — first generation/related
- Formulation / route
- Single-use oral inhalation product for acute agitation in a certified setting
- Psychiatric-use scope
- Antipsychotic or closely related dopamine-antagonist drug
MED-109Prepopulated workbench
No brand or product examples populated
- Class
- Antipsychotics — second generation/newer
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Second-generation or newer antipsychotic
MED-106Prepopulated workbench
No brand or product examples populated
- Class
- Antipsychotics — second generation/newer
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Second-generation or newer antipsychotic
MED-285Prepopulated workbench
LSD
- Class
- Nonprescription/emerging psychoactive — psychedelic/entactogen
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Investigational psychedelic-assisted treatment and nonmedical exposure
MED-278Prepopulated workbench
No brand or product examples populated
- Class
- Nonprescription/emerging psychoactive — nutrient/amino acid
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Nonprescription sleep/anxiety exposure
MED-035Prepopulated workbench
No brand or product examples populated
- Class
- Antidepressants — tricyclic/tetracyclic
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Tricyclic or tetracyclic antidepressant
MED-205Prepopulated workbench
No brand or product examples populated
- Class
- Insomnia — melatonin/circadian
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Sleep/circadian product; formulation and quality vary
MED-094Prepopulated workbench
No brand or product examples populated
- Class
- Antipsychotics — first generation/related
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Antipsychotic or closely related dopamine-antagonist drug
MED-255Prepopulated workbench
No brand or product examples populated
- Class
- Psychiatric adjuncts — hyperprolactinemia/NMS/catatonia
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Nonpsychotropic or adjunctive use in medication adverse effects, catatonia, or NMS
MED-195Prepopulated workbench
No brand or product examples populated
- Class
- Anxiolytics/symptom-targeted
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Anxiolytic or symptom-targeted off-label psychiatric medication
MED-257Prepopulated workbench
No brand or product examples populated
- Class
- Psychiatric adjuncts — metabolic mitigation
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Nonpsychotropic metabolic co-medication used to mitigate antipsychotic-associated weight/metabolic effects
MED-212Prepopulated workbench
No brand or product examples populated
- Class
- Substance-use disorder — opioid
- Formulation / route
- Oral solution/tablet administered through regulated opioid treatment programs
- Psychiatric-use scope
- Opioid use disorder maintenance; also a pain medication in other settings
MED-280Prepopulated workbench
No brand or product examples populated
- Class
- Nonprescription/emerging psychoactive — stimulant
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Nonmedical stimulant exposure and stimulant use disorder
MED-145Prepopulated workbench
Desoxyn
- Class
- ADHD/psychostimulants — amphetamine
- Formulation / route
- Oral tablet
- Psychiatric-use scope
- Prescription amphetamine stimulant for ADHD or narcolepsy
MED-148Prepopulated workbench
No brand or product examples populated
- Class
- ADHD/psychostimulants — methylphenidate
- Formulation / route
- Oral extended-release capsule/tablet/liquid/ODT; multiple release technologies
- Psychiatric-use scope
- Prescription methylphenidate-class stimulant for ADHD
MED-147Prepopulated workbench
No brand or product examples populated
- Class
- ADHD/psychostimulants — methylphenidate
- Formulation / route
- Oral immediate-release tablet/solution/chewable products
- Psychiatric-use scope
- Prescription methylphenidate-class stimulant for ADHD
MED-149Prepopulated workbench
Concerta
- Class
- ADHD/psychostimulants — methylphenidate
- Formulation / route
- Oral osmotic-release tablet; once daily
- Psychiatric-use scope
- Prescription methylphenidate-class stimulant for ADHD
MED-150Prepopulated workbench
Daytrana
- Class
- ADHD/psychostimulants — methylphenidate
- Formulation / route
- Transdermal system; once daily wear period
- Psychiatric-use scope
- Prescription methylphenidate-class stimulant for ADHD
MED-023Prepopulated workbench
No brand or product examples populated
- Class
- Antidepressants — other/multimodal
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Antidepressant; mechanism and approved indications vary
MED-180Prepopulated workbench
No brand or product examples populated
- Class
- Benzodiazepines
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Benzodiazepine-class anxiolytic, sedative, anticonvulsant, or procedural agent
MED-284Prepopulated workbench
MDMA
- Class
- Nonprescription/emerging psychoactive — psychedelic/entactogen
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Investigational MDMA-assisted therapy and nonmedical exposure
MED-011Prepopulated workbench
No brand or product examples populated
- Class
- Antidepressants — SNRI/dual reuptake
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- SNRI; FDA-approved in the US for fibromyalgia, not major depressive disorder; antidepressant use is jurisdiction-specific
MED-112Prepopulated workbench
Bysanti
- Class
- Antipsychotics — second generation/newer
- Formulation / route
- Oral tablet; twice daily
- Psychiatric-use scope
- Second-generation or newer antipsychotic
MED-013Prepopulated workbench
No brand or product examples populated
- Class
- Antidepressants — other/multimodal
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Antidepressant; mechanism and approved indications vary
MED-142Prepopulated workbench
Adderall · Adderall XR · Mydayis
- Class
- ADHD/psychostimulants — amphetamine
- Formulation / route
- Oral immediate- and extended-release products
- Psychiatric-use scope
- Prescription amphetamine stimulant for ADHD or narcolepsy
MED-043Prepopulated workbench
No brand or product examples populated
- Class
- Antidepressants — MAOI
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Monoamine oxidase inhibitor antidepressant
MED-161Prepopulated workbench
No brand or product examples populated
- Class
- Wake-promoting/narcolepsy
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Wake-promoting or narcolepsy/cataplexy treatment
MED-081Prepopulated workbench
No brand or product examples populated
- Class
- Antipsychotics — first generation/related
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Antipsychotic or closely related dopamine-antagonist drug
MED-225Prepopulated workbench
No brand or product examples populated
- Class
- Substance-use disorder — opioid
- Formulation / route
- Oral prolonged-release product; OUD use jurisdiction-specific
- Psychiatric-use scope
- Alternative opioid agonist treatment in selected non-US systems
MED-242Prepopulated workbench
NAC
- Class
- Substance-use disorder — cannabis
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Investigational/off-label cannabis-use-disorder and psychiatric adjunct
MED-244Prepopulated workbench
No brand or product examples populated
- Class
- Substance-use disorder — cannabis
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- FDA-approved synthetic cannabinoid for chemotherapy nausea; investigational/off-label for cannabis use disorder
MED-245Prepopulated workbench
Sativex
- Class
- Substance-use disorder — cannabis
- Formulation / route
- Oromucosal spray
- Psychiatric-use scope
- Non-US cannabinoid medicine; investigational for cannabis use disorder
MED-229Prepopulated workbench
Opvee
- Class
- Substance-use disorder — alcohol
- Formulation / route
- Intranasal spray for opioid overdose reversal
- Psychiatric-use scope
- Opioid overdose rescue; not alcohol-use-disorder treatment
MED-228Prepopulated workbench
Selincro
- Class
- Substance-use disorder — alcohol
- Formulation / route
- Oral tablet; as-needed regimen in authorized jurisdictions
- Psychiatric-use scope
- Alcohol consumption reduction treatment in selected non-US jurisdictions
MED-223Prepopulated workbench
Narcan · Kloxxado · Zimhi · generics
- Class
- Substance-use disorder — opioid
- Formulation / route
- Intranasal spray or injection for emergency opioid overdose reversal
- Psychiatric-use scope
- Overdose rescue; not maintenance treatment
MED-222Prepopulated workbench
Vivitrol
- Class
- Substance-use disorder — opioid
- Formulation / route
- Intramuscular extended-release suspension; every 4 weeks
- Psychiatric-use scope
- Opioid and alcohol use disorder relapse-prevention treatment
MED-221Prepopulated workbench
No brand or product examples populated
- Class
- Substance-use disorder — opioid
- Formulation / route
- Oral tablet; daily
- Psychiatric-use scope
- Opioid and alcohol use disorder relapse-prevention treatment
MED-015Prepopulated workbench
No brand or product examples populated
- Class
- Antidepressants — other/multimodal
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Antidepressant; mechanism and approved indications vary
MED-236Prepopulated workbench
Nicotrol Inhaler
- Class
- Substance-use disorder — nicotine
- Formulation / route
- Oral inhalation cartridge
- Psychiatric-use scope
- Nicotine-dependence treatment
MED-237Prepopulated workbench
Nicotrol NS
- Class
- Substance-use disorder — nicotine
- Formulation / route
- Intranasal spray
- Psychiatric-use scope
- Nicotine-dependence treatment
MED-234Prepopulated workbench
No brand or product examples populated
- Class
- Substance-use disorder — nicotine
- Formulation / route
- Buccal gum; intermittent dosing
- Psychiatric-use scope
- Nicotine-dependence treatment
MED-235Prepopulated workbench
No brand or product examples populated
- Class
- Substance-use disorder — nicotine
- Formulation / route
- Buccal lozenge; intermittent dosing
- Psychiatric-use scope
- Nicotine-dependence treatment
MED-233Prepopulated workbench
No brand or product examples populated
- Class
- Substance-use disorder — nicotine
- Formulation / route
- Transdermal patch; typically once daily
- Psychiatric-use scope
- Nicotine-dependence treatment
MED-183Prepopulated workbench
No brand or product examples populated
- Class
- Benzodiazepines
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Benzodiazepine-class anxiolytic, sedative, anticonvulsant, or procedural agent
MED-282Prepopulated workbench
No brand or product examples populated
- Class
- Nonprescription/emerging psychoactive — stimulant
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Nonmedical stimulant exposure requiring separation from prescribed therapeutic use
MED-026Prepopulated workbench
No brand or product examples populated
- Class
- Antidepressants — tricyclic/tetracyclic
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Tricyclic or tetracyclic antidepressant
MED-100Prepopulated workbench
No brand or product examples populated
- Class
- Antipsychotics — second generation/newer
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Second-generation or newer antipsychotic
MED-126Prepopulated workbench
Zyprexa Relprevv
- Class
- Antipsychotics — long-acting injectable
- Formulation / route
- Intramuscular extended-release suspension; every 2 or 4 weeks
- Psychiatric-use scope
- Long-acting antipsychotic formulation
MED-136Prepopulated workbench
Zyprexa IntraMuscular
- Class
- Emergency agitation — short-acting formulations
- Formulation / route
- Short-acting intramuscular injection
- Psychiatric-use scope
- Short-acting formulation used in emergency agitation or acute symptom management
MED-113Prepopulated workbench
Symbyax
- Class
- Antipsychotics — fixed combinations
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Bipolar depression and treatment-resistant depression
MED-114Prepopulated workbench
Lybalvi
- Class
- Antipsychotics — fixed combinations
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Schizophrenia and bipolar I disorder
MED-275Prepopulated workbench
No brand or product examples populated
- Class
- Nonprescription/emerging psychoactive — nutrient/amino acid
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Nonprescription or prescription adjunct exposure
MED-231Prepopulated workbench
No brand or product examples populated
- Class
- Substance-use disorder — alcohol
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Approved or off-label medication considered in alcohol use disorder
MED-024Prepopulated workbench
No brand or product examples populated
- Class
- Antidepressants — other/multimodal
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Antidepressant; mechanism and approved indications vary
MED-170Prepopulated workbench
No brand or product examples populated
- Class
- Benzodiazepines
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Benzodiazepine-class anxiolytic, sedative, anticonvulsant, or procedural agent
MED-063Prepopulated workbench
No brand or product examples populated
- Class
- Mood stabilizers/antiseizure — core
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Core mood stabilizer/antiseizure medication; psychiatric and epilepsy indications must be separated
MED-099Prepopulated workbench
No brand or product examples populated
- Class
- Antipsychotics — second generation/newer
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Second-generation or newer antipsychotic
MED-123Prepopulated workbench
Erzofri
- Class
- Antipsychotics — long-acting injectable
- Formulation / route
- Intramuscular extended-release suspension; monthly
- Psychiatric-use scope
- Long-acting antipsychotic formulation
MED-122Prepopulated workbench
Invega Sustenna
- Class
- Antipsychotics — long-acting injectable
- Formulation / route
- Intramuscular extended-release suspension; monthly
- Psychiatric-use scope
- Long-acting antipsychotic formulation
MED-124Prepopulated workbench
Invega Trinza
- Class
- Antipsychotics — long-acting injectable
- Formulation / route
- Intramuscular extended-release suspension; every 3 months after stabilization
- Psychiatric-use scope
- Long-acting antipsychotic formulation
MED-125Prepopulated workbench
Invega Hafyera
- Class
- Antipsychotics — long-acting injectable
- Formulation / route
- Intramuscular extended-release suspension; every 6 months after stabilization
- Psychiatric-use scope
- Long-acting antipsychotic formulation
MED-005Prepopulated workbench
No brand or product examples populated
- Class
- Antidepressants — SSRI
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- SSRI antidepressant; mood/anxiety/OCD indications vary
MED-095Prepopulated workbench
No brand or product examples populated
- Class
- Antipsychotics — first generation/related
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Antipsychotic or closely related dopamine-antagonist drug
MED-076Prepopulated workbench
No brand or product examples populated
- Class
- Antipsychotics — first generation/related
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Antipsychotic or closely related dopamine-antagonist drug
MED-038Prepopulated workbench
No brand or product examples populated
- Class
- Antidepressants — MAOI
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Monoamine oxidase inhibitor antidepressant
MED-072Prepopulated workbench
No brand or product examples populated
- Class
- Mood stabilizers/antiseizure — other
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Antiseizure medication with off-label psychiatric use; established bipolar efficacy must not be assumed
MED-071Prepopulated workbench
No brand or product examples populated
- Class
- Mood stabilizers/antiseizure — other
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Antiseizure medication with off-label psychiatric use; established bipolar efficacy must not be assumed
MED-110Prepopulated workbench
No brand or product examples populated
- Class
- Antipsychotics — second generation/newer
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Second-generation or newer antipsychotic
MED-082Prepopulated workbench
No brand or product examples populated
- Class
- Antipsychotics — first generation/related
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Antipsychotic or closely related dopamine-antagonist drug
MED-096Prepopulated workbench
No brand or product examples populated
- Class
- Antipsychotics — first generation/related
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Antipsychotic or closely related dopamine-antagonist drug
MED-134Prepopulated workbench
No brand or product examples populated
- Class
- Antipsychotics — long-acting injectable
- Formulation / route
- Intramuscular depot injection; historical/limited availability
- Psychiatric-use scope
- Long-acting antipsychotic formulation
MED-164Prepopulated workbench
No brand or product examples populated
- Class
- Wake-promoting/narcolepsy
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Wake-promoting or narcolepsy/cataplexy treatment
MED-052Prepopulated workbench
No brand or product examples populated
- Class
- Antidepressant augmentation
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Dopamine agonist used off-label for augmentation/bipolar depression
MED-186Prepopulated workbench
No brand or product examples populated
- Class
- Benzodiazepines
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Benzodiazepine-class anxiolytic, sedative, anticonvulsant, or procedural agent
MED-192Prepopulated workbench
No brand or product examples populated
- Class
- Anxiolytics/symptom-targeted
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Anxiolytic or symptom-targeted off-label psychiatric medication
MED-066Prepopulated workbench
No brand or product examples populated
- Class
- Mood stabilizers/antiseizure — other
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Antiseizure medication with off-label psychiatric use; established bipolar efficacy must not be assumed
MED-241Prepopulated workbench
No brand or product examples populated
- Class
- Substance-use disorder — stimulant
- Formulation / route
- Regimen-specific
- Psychiatric-use scope
- Investigational/off-label strategy for stimulant use disorder
MED-084Prepopulated workbench
No brand or product examples populated
- Class
- Antipsychotics — first generation/related
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Antipsychotic or closely related dopamine-antagonist drug
MED-208Prepopulated workbench
No brand or product examples populated
- Class
- Insomnia — antihistamine/legacy sedative
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Sedating antihistamine, barbiturate, or legacy hypnotic
MED-191Prepopulated workbench
No brand or product examples populated
- Class
- Anxiolytics/symptom-targeted
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Anxiolytic or symptom-targeted off-label psychiatric medication
MED-033Prepopulated workbench
No brand or product examples populated
- Class
- Antidepressants — tricyclic/tetracyclic
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Tricyclic or tetracyclic antidepressant
MED-283Prepopulated workbench
No brand or product examples populated
- Class
- Nonprescription/emerging psychoactive — psychedelic/entactogen
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Investigational psychedelic-assisted treatment and nonmedical exposure
MED-179Prepopulated workbench
No brand or product examples populated
- Class
- Benzodiazepines
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Benzodiazepine-class anxiolytic, sedative, anticonvulsant, or procedural agent
MED-101Prepopulated workbench
No brand or product examples populated
- Class
- Antipsychotics — second generation/newer
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Second-generation or newer antipsychotic
MED-053Prepopulated workbench
Seroquel XR
- Class
- Antidepressant augmentation
- Formulation / route
- Oral extended-release tablet; once daily
- Psychiatric-use scope
- FDA-approved extended-release product used for depressive and bipolar indications/augmentation
MED-203Prepopulated workbench
No brand or product examples populated
- Class
- Insomnia — melatonin/circadian
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Melatonin-receptor or circadian-rhythm treatment
MED-022Prepopulated workbench
No brand or product examples populated
- Class
- Antidepressants — other/multimodal
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Antidepressant; mechanism and approved indications vary
MED-098Prepopulated workbench
No brand or product examples populated
- Class
- Antipsychotics — second generation/newer
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Second-generation or newer antipsychotic
MED-118Prepopulated workbench
Rykindo
- Class
- Antipsychotics — long-acting injectable
- Formulation / route
- Intramuscular extended-release suspension; every 2 weeks
- Psychiatric-use scope
- Long-acting antipsychotic formulation
MED-121Prepopulated workbench
Risvan
- Class
- Antipsychotics — long-acting injectable
- Formulation / route
- Intramuscular injection; once monthly
- Psychiatric-use scope
- Long-acting antipsychotic formulation
MED-120Prepopulated workbench
Uzedy
- Class
- Antipsychotics — long-acting injectable
- Formulation / route
- Subcutaneous injection; once monthly or every 2 months
- Psychiatric-use scope
- Long-acting antipsychotic formulation
MED-119Prepopulated workbench
Perseris
- Class
- Antipsychotics — long-acting injectable
- Formulation / route
- Subcutaneous injection; once monthly
- Psychiatric-use scope
- Long-acting antipsychotic formulation
MED-117Prepopulated workbench
Risperdal Consta
- Class
- Antipsychotics — long-acting injectable
- Formulation / route
- Intramuscular extended-release suspension; every 2 weeks
- Psychiatric-use scope
- Long-acting antipsychotic formulation
MED-261Prepopulated workbench
No brand or product examples populated
- Class
- Special psychiatric indications — cholinesterase inhibitor appendix
- Formulation / route
- Oral capsule/solution or transdermal patch
- Psychiatric-use scope
- Cognitive-disorder medication included for rare-exposure completeness
MED-055Prepopulated workbench
SAMe
- Class
- Antidepressant augmentation
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Nonprescription antidepressant adjunct exposure
MED-271Prepopulated workbench
No brand or product examples populated
- Class
- Nonprescription/emerging psychoactive — cannabinoid/plant
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Nonprescription mood exposure
MED-210Prepopulated workbench
Seconal (historical)
- Class
- Insomnia — antihistamine/legacy sedative
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Sedating antihistamine, barbiturate, or legacy hypnotic
MED-041Prepopulated workbench
No brand or product examples populated
- Class
- Antidepressants — MAOI
- Formulation / route
- Oral tablet/capsule; approved primarily for Parkinson disease
- Psychiatric-use scope
- MAO inhibitor; oral formulation is not the same psychiatric product as transdermal selegiline
MED-042Prepopulated workbench
Emsam
- Class
- Antidepressants — MAOI
- Formulation / route
- Transdermal system; changed every 24 hours
- Psychiatric-use scope
- Monoamine oxidase inhibitor antidepressant
MED-152Prepopulated workbench
Azstarys
- Class
- ADHD/psychostimulants — methylphenidate
- Formulation / route
- Oral capsule; once daily
- Psychiatric-use scope
- Prescription methylphenidate-class stimulant for ADHD
MED-092Prepopulated workbench
No brand or product examples populated
- Class
- Antipsychotics — first generation/related
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Antipsychotic or closely related dopamine-antagonist drug
MED-002Prepopulated workbench
No brand or product examples populated
- Class
- Antidepressants — SSRI
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- SSRI antidepressant; mood/anxiety/OCD indications vary
MED-167Prepopulated workbench
Lumryz
- Class
- Wake-promoting/narcolepsy
- Formulation / route
- Oral extended-release suspension; once nightly
- Psychiatric-use scope
- Wake-promoting or narcolepsy/cataplexy treatment
MED-165Prepopulated workbench
Xyrem · authorized generics
- Class
- Wake-promoting/narcolepsy
- Formulation / route
- Oral solution; split-night dosing
- Psychiatric-use scope
- Wake-promoting or narcolepsy/cataplexy treatment
MED-163Prepopulated workbench
No brand or product examples populated
- Class
- Wake-promoting/narcolepsy
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Wake-promoting or narcolepsy/cataplexy treatment
MED-267Prepopulated workbench
No brand or product examples populated
- Class
- Nonprescription/emerging psychoactive — cannabinoid/plant
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Nonprescription antidepressant exposure
MED-089Prepopulated workbench
No brand or product examples populated
- Class
- Antipsychotics — first generation/related
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Antipsychotic or closely related dopamine-antagonist drug
MED-200Prepopulated workbench
No brand or product examples populated
- Class
- Insomnia — orexin antagonist
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Dual orexin receptor antagonist for insomnia
MED-263Prepopulated workbench
No brand or product examples populated
- Class
- Special psychiatric indications — cholinesterase inhibitor appendix
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Cognitive-disorder medication included for rare-exposure completeness
MED-204Prepopulated workbench
No brand or product examples populated
- Class
- Insomnia — melatonin/circadian
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Melatonin-receptor or circadian-rhythm treatment
MED-171Prepopulated workbench
No brand or product examples populated
- Class
- Benzodiazepines
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Benzodiazepine-class anxiolytic, sedative, anticonvulsant, or procedural agent
MED-252Prepopulated workbench
No brand or product examples populated
- Class
- Psychiatric adjuncts — movement disorders/EPS
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Treatment of extrapyramidal symptoms or tardive dyskinesia; indication varies
MED-083Prepopulated workbench
No brand or product examples populated
- Class
- Antipsychotics — first generation/related
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Antipsychotic or closely related dopamine-antagonist drug
MED-078Prepopulated workbench
No brand or product examples populated
- Class
- Antipsychotics — first generation/related
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Antipsychotic or closely related dopamine-antagonist drug
MED-069Prepopulated workbench
No brand or product examples populated
- Class
- Mood stabilizers/antiseizure — other
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Antiseizure medication with off-label psychiatric use; established bipolar efficacy must not be assumed
MED-021Prepopulated workbench
No brand or product examples populated
- Class
- Antidepressants — other/multimodal
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Antidepressant; mechanism and approved indications vary
MED-090Prepopulated workbench
No brand or product examples populated
- Class
- Antipsychotics — first generation/related
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Antipsychotic or closely related dopamine-antagonist drug
MED-194Prepopulated workbench
No brand or product examples populated
- Class
- Anxiolytics/symptom-targeted
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Anxiolytic or symptom-targeted off-label psychiatric medication
MED-064Prepopulated workbench
No brand or product examples populated
- Class
- Mood stabilizers/antiseizure — other
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Antiseizure medication with off-label psychiatric use; established bipolar efficacy must not be assumed
MED-039Prepopulated workbench
No brand or product examples populated
- Class
- Antidepressants — MAOI
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Monoamine oxidase inhibitor antidepressant
MED-014Prepopulated workbench
No brand or product examples populated
- Class
- Antidepressants — other/multimodal
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Antidepressant; mechanism and approved indications vary
MED-176Prepopulated workbench
No brand or product examples populated
- Class
- Benzodiazepines
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Benzodiazepine-class anxiolytic, sedative, anticonvulsant, or procedural agent
MED-077Prepopulated workbench
No brand or product examples populated
- Class
- Antipsychotics — first generation/related
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Antipsychotic or closely related dopamine-antagonist drug
MED-249Prepopulated workbench
No brand or product examples populated
- Class
- Psychiatric adjuncts — movement disorders/EPS
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Treatment of extrapyramidal symptoms or tardive dyskinesia; indication varies
MED-032Prepopulated workbench
No brand or product examples populated
- Class
- Antidepressants — tricyclic/tetracyclic
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Tricyclic or tetracyclic antidepressant
MED-250Prepopulated workbench
No brand or product examples populated
- Class
- Psychiatric adjuncts — movement disorders/EPS
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Treatment of extrapyramidal symptoms or tardive dyskinesia; indication varies
MED-268Prepopulated workbench
No brand or product examples populated
- Class
- Nonprescription/emerging psychoactive — cannabinoid/plant
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Nonprescription sleep/anxiety exposure
MED-060Prepopulated workbench
No brand or product examples populated
- Class
- Mood stabilizers/antiseizure — core
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Core mood stabilizer/antiseizure medication; psychiatric and epilepsy indications must be separated
MED-058Prepopulated workbench
No brand or product examples populated
- Class
- Mood stabilizers/antiseizure — core
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Core mood stabilizer/antiseizure medication; psychiatric and epilepsy indications must be separated
MED-232Prepopulated workbench
No brand or product examples populated
- Class
- Substance-use disorder — alcohol
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Approved or off-label medication considered in alcohol use disorder
MED-007Prepopulated workbench
No brand or product examples populated
- Class
- Antidepressants — SNRI/dual reuptake
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- SNRI antidepressant; approved psychiatric indications vary
MED-016Prepopulated workbench
No brand or product examples populated
- Class
- Antidepressants — other/multimodal
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Antidepressant; mechanism and approved indications vary
MED-155Prepopulated workbench
Qelbree
- Class
- ADHD/psychostimulants — nonstimulant
- Formulation / route
- Oral extended-release capsule; once daily
- Psychiatric-use scope
- Nonstimulant ADHD treatment
MED-017Prepopulated workbench
No brand or product examples populated
- Class
- Antidepressants — other/multimodal
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Antidepressant; mechanism and approved indications vary
MED-111Prepopulated workbench
Cobenfy
- Class
- Antipsychotics — second generation/newer
- Formulation / route
- Oral capsule; twice daily
- Psychiatric-use scope
- Second-generation or newer antipsychotic
MED-197Prepopulated workbench
No brand or product examples populated
- Class
- Insomnia — Z-drug
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Nonbenzodiazepine hypnotic
MED-102Prepopulated workbench
No brand or product examples populated
- Class
- Antipsychotics — second generation/newer
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Second-generation or newer antipsychotic
MED-137Prepopulated workbench
Geodon for Injection
- Class
- Emergency agitation — short-acting formulations
- Formulation / route
- Short-acting intramuscular injection
- Psychiatric-use scope
- Short-acting formulation used in emergency agitation or acute symptom management
MED-196Prepopulated workbench
No brand or product examples populated
- Class
- Insomnia — Z-drug
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Nonbenzodiazepine hypnotic
MED-068Prepopulated workbench
No brand or product examples populated
- Class
- Mood stabilizers/antiseizure — other
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Antiseizure medication with off-label psychiatric use; established bipolar efficacy must not be assumed
MED-199Prepopulated workbench
No brand or product examples populated
- Class
- Insomnia — Z-drug
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Nonbenzodiazepine hypnotic
MED-091Prepopulated workbench
No brand or product examples populated
- Class
- Antipsychotics — first generation/related
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Antipsychotic or closely related dopamine-antagonist drug
MED-087Prepopulated workbench
No brand or product examples populated
- Class
- Antipsychotics — first generation/related
- Formulation / route
- Oral; formulation varies
- Psychiatric-use scope
- Antipsychotic or closely related dopamine-antagonist drug
MED-133Prepopulated workbench
No brand or product examples populated
- Class
- Antipsychotics — long-acting injectable
- Formulation / route
- Short-acting intramuscular injection; product-specific
- Psychiatric-use scope
- Long-acting antipsychotic formulation
MED-132Prepopulated workbench
No brand or product examples populated
- Class
- Antipsychotics — long-acting injectable
- Formulation / route
- Intramuscular depot injection; product-specific interval
- Psychiatric-use scope
- Long-acting antipsychotic formulation
MED-050Prepopulated workbench
Zurzuvae
- Class
- Antidepressants — perinatal neuroactive steroid
- Formulation / route
- Oral capsule; 14-day treatment course
- Psychiatric-use scope
- FDA-approved treatment of postpartum depression in adults